368 related articles for article (PubMed ID: 28341415)
1. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
[TBL] [Abstract][Full Text] [Related]
2. CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.
Núñez J; Llàcer P; García-Blas S; Bonanad C; Ventura S; Núñez JM; Sánchez R; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Chamorro C; Bodi V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Rodríguez E; Mollar A; Palau P; Bosch MJ; Bertomeu-González V; Lupón J; Navarro J; Chorro FJ; Górriz JL; Sanchis J; Voors AA; Bayés-Genís A
Am J Med; 2020 Mar; 133(3):370-380.e4. PubMed ID: 31422111
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
5. Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failure.
Núñez J; Llàcer P; Núñez E; Ventura S; Bonanad C; Bodí V; Miñana G; Santas E; Mascarell B; Fonarow GC; Chorro FJ; Sanchis J
Int J Cardiol; 2014 Jul; 174(3):516-23. PubMed ID: 24801083
[TBL] [Abstract][Full Text] [Related]
6. Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction.
de la Espriella R; Núñez E; Llàcer P; García-Blas S; Ventura S; Núñez JM; Sánchez R; Fácila L; Vaquer JM; Bodí V; Santas E; Miñana G; Mollar A; Núñez G; Chorro FJ; Górriz JL; Sanchis J; Bayés-Genis A; Núñez J
Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):616-623. PubMed ID: 32624444
[TBL] [Abstract][Full Text] [Related]
7. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
8. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
9. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
10. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
11. Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial.
Brisco MA; Zile MR; Hanberg JS; Wilson FP; Parikh CR; Coca SG; Tang WH; Testani JM
J Card Fail; 2016 Oct; 22(10):753-60. PubMed ID: 27374839
[TBL] [Abstract][Full Text] [Related]
12. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial.
Mullens W; Verbrugge FH; Nijst P; Martens P; Tartaglia K; Theunissen E; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2018 Nov; 20(11):1591-1600. PubMed ID: 30238574
[TBL] [Abstract][Full Text] [Related]
14. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W; Dauw J; Martens P; Meekers E; Nijst P; Verbrugge FH; Chenot F; Moubayed S; Dierckx R; Blouard P; Derthoo D; Smolders W; Ector B; Hulselmans M; Lochy S; Raes D; Van Craenenbroeck E; Vandekerckhove H; Hofkens PJ; Goossens K; Pouleur AC; De Ceuninck M; Gabriel L; Timmermans P; Prihadi EA; Van Durme F; Depauw M; Vervloet D; Viaene E; Vachiery JL; Tartaglia K; Ter Maaten JM; Bruckers L; Droogne W; Troisfontaines P; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M
Eur J Heart Fail; 2022 Sep; 24(9):1601-1610. PubMed ID: 35733283
[TBL] [Abstract][Full Text] [Related]
15. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure.
Grodin JL; Stevens SR; de Las Fuentes L; Kiernan M; Birati EY; Gupta D; Bart BA; Felker GM; Chen HH; Butler J; Dávila-Román VG; Margulies KB; Hernandez AF; Anstrom KJ; Tang WH
J Card Fail; 2016 Jan; 22(1):26-32. PubMed ID: 26209004
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction.
Llàcer P; Núñez J; Croset F; García M; Fabregate M; Ruiz R; López G; Fernández C; Del Hoyo B; Campos J; Gomis A; Manzano L
Clin Cardiol; 2023 Aug; 46(8):906-913. PubMed ID: 37287326
[TBL] [Abstract][Full Text] [Related]
17. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
[TBL] [Abstract][Full Text] [Related]
18. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
[TBL] [Abstract][Full Text] [Related]
19. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
[TBL] [Abstract][Full Text] [Related]
20. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
